APA (7th ed.) Citation

(2016). High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.

Chicago Style (17th ed.) Citation

High Dose CD11c-driven IL15 Is Sufficient to Drive NK Cell Maturation and Anti-tumor Activity in a Trans-presentation Independent Manner. 2016.

MLA (8th ed.) Citation

High Dose CD11c-driven IL15 Is Sufficient to Drive NK Cell Maturation and Anti-tumor Activity in a Trans-presentation Independent Manner. 2016.

Warning: These citations may not always be 100% accurate.